melatonin and dabrafenib

melatonin has been researched along with dabrafenib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, J; Chang, A; Gao, Y; Gu, W; Li, Z; Liao, Y; Tang, R; Wang, H	1

Other Studies

1 other study(ies) available for melatonin and dabrafenib

Article	Year
Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling. Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:20 Topics: Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Drug Synergism; Humans; Imidazoles; Melatonin; Models, Biological; Neoplasm Invasiveness; Oximes; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Signal Transduction; Telomerase; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms	2020

Article

Year

Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling.

Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:20

Topics: Apoptosis; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; Drug Synergism; Humans; Imidazoles; Melatonin; Models, Biological; Neoplasm Invasiveness; Oximes; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Signal Transduction; Telomerase; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms

2020